The article focuses on the issue of unethical acts of companies to accumulate financial benefits of an unethical innovation. Ethical debates have little significance, other than to enshroud sometimes unpleasant ambitions of scientists, executives, politicians and voters. The author highlights a case of trade of aborted fetus organs. Traders presented the ethical defense that the dead fetuses would otherwise be wasted, and these can serve in the research against diseases like Alzheimer, Parkinson and AIDS. There has been debates on the possibility of nanotechnology, information technology and biotechnology uniting to form a self-replicating, intelligent life force that, in time, would perhaps destroy much life on Earth. The utilitarian "scientific ethic" fostered to counter effects of such innovations is sharply different from ethics promoted by environmentalists and economists. Scientists and sponsoring companies are even less ethical, more because they can reap financial benefits of any unethical innovation, and are very willing to perfume the bad with promises of good.